Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali

Background. The monovalent meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed for use in the “meningitis belt” of sub-Saharan Africa. Mali was 1 of 3 countries selected for early introduction. As this is a new vaccine, postlicensure surveillance is particularly important to identif...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Vannice, Kirsten S., Keita, Modibo, Sow, Samba O., Durbin, Anna P., Omer, Saad B., Moulton, Lawrence H., Yaméogo, Téné M., Zuber, Patrick L. F., Onwuchekwa, Uma, Sacko, Massambou, Diomandé, Fabien V. K., Halsey, Neal A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2015
Témata:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639483/
https://ncbi.nlm.nih.gov/pubmed/26553680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ497
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky